Tag: PMD

  • Psychemedics Corp Valuation – April 2017 $PMD

    Psychemedics Corp Valuation – April 2017 $PMD

    Psychemedics Corp. is suitable for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the small size, high PEmg and PB ratios.

  • Psychemedics Corp Valuation – August 2016 $PMD

    Psychemedics Corp Valuation – August 2016 $PMD

    Psychemedics Corp. is suitable for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the small size, insufficient earnings growth over the last ten years, and the high PEmg and PB ratios.

  • Psychemedics Corp Stock Valuation – February 2016 $PMD

    Psychemedics Corp Stock Valuation – February 2016 $PMD

    Psychemedics Corp. is suitable for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the small size, insufficient earnings growth over the last ten years, and the high PEmg and PB ratios.

  • Psychemedics Corporation Valuation – November 2015 Update $PMD

    Psychemedics Corporation Valuation – November 2015 Update $PMD

    Psychemedics Corporation qualifies for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the small size, insufficient earnings growth over the last ten years, and the high PEmg and PB ratios.

  • Psychemedics Corporation Analysis – August 2015 Update $PMD

    Psychemedics Corporation Analysis – August 2015 Update $PMD

    Psychemedics Corporation qualifies for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the company size, insufficient earnings growth over the last ten years, and the high PEmg and PB ratios.

  • 21 Companies in the Spotlight This Week – 5/9/15

    21 Companies in the Spotlight This Week – 5/9/15

    We evaluated 21 different companies this week to determine whether they are suitable for Defensive Investors, those unwilling to do substantial research, or Enterprising Investors, those who are willing to do such research. We also put each company through the ModernGraham valuation model based on Benjamin Graham’s value investing formulas in order to determine an intrinsic value for each. Here’s a summary of the ModernGraham Valuations.

  • Psychemedics Corporation Quarterly Valuation – May 2015 $PMD

    Psychemedics Corporation Quarterly Valuation – May 2015 $PMD

    Psychemedics Corporation is suitable for the Enterprising Investor but not for the Defensive Investor. The Defensive Investor is concerned by the small company size, the low earnings growth over the last ten years, and the high PEmg and PB ratios, while the Enterprising Investor has no initial concerns.

  • Psychemedics Corporation Quarterly Valuation – January 2015 $PMD

    Psychemedics Corporation Quarterly Valuation – January 2015 $PMD

    Psychemedics Corporation is suitable for the Enterprising Investor but not for the Defensive Investor. The Defensive Investor is concerned by the small size, insufficient growth over the last ten years and the high PEmg and PB ratios.

  • 13 Companies in the Spotlight This Week – 10/4/14

    13 Companies in the Spotlight This Week – 10/4/14

    We evaluated 17 different companies this week to determine whether they are suitable for Defensive Investors, those unwilling to do substantial research, or Enterprising Investors, those who are willing to do such research. We also put each company through the ModernGraham valuation model based on Benjamin Graham’s value investing formulas in order to determine an intrinsic […]

  • Psychemedics Corporation Quarterly Stock Valuation – September 2014 $PMD

    Psychemedics Corporation Quarterly Stock Valuation – September 2014 $PMD

    Psychemedics Corporation is suitable for the Enterprising Investor but not the Defensive Investor. The Defensive Investor is concerned with the small market cap size, the insufficient earnings growth over the last ten years and the high PEmg and PB ratios, while the company passes all of the Enterprising Investor’s requirements.